| Filed On | Filing |
|---|---|
| 20 Aug 2026 |
Form 4: Tousignant Jennifer, Chief Legal Officer
Sold 14,212 shares ($348K) · Received 10,000 shares by exercise or conversion ($144K) |
| 18 Aug 2026 |
Form 4: Tripuraneni Radhika, Chief Medical Officer
Received 40,000 shares by exercise or conversion ($528K) |
| 02 Jul 2026 |
Form 4: Cain Christopher W., Director
Granted 32,341 Stock Option (Right to Buy) |
| 02 Jul 2026 |
Form 4: Ajer Jeffrey Robert, Director
Granted 32,341 Stock Option (Right to Buy) |
| 02 Jul 2026 |
Form 4: Moses Jennifer K., Director
Granted 32,341 Stock Option (Right to Buy) |
| 02 Jul 2026 |
Form 4: Gheuens Sarah, Director
Granted 32,341 Stock Option (Right to Buy) |
| 02 Jul 2026 |
Form 4: Kiselak Tomas, Director
Granted 32,341 Stock Option (Right to Buy) |
| 02 Jul 2026 |
Form 4: Morris Arlene, Director
Granted 32,341 Stock Option (Right to Buy) |
| 13 May 2026 |
Form 4: Fairmount Funds Management Llc, Director and 2 others
Bought 1,176,470 shares ($20M) |
| 04 Mar 2026 |
Form 4: Tousignant Jennifer, Chief Legal Officer
Granted 119,300 Stock Option (Right to Buy) · Granted 23,850 Restricted Stock Units · Received 5,169 shares by exercise or conversion · 1 more |
| 04 Mar 2026 |
Form 4: Harmon Seth, Chief Financial Officer
Granted 102,850 Stock Option (Right to Buy) · Granted 20,550 Restricted Stock Units · Received 6,267 shares by exercise or conversion · 1 more |
| 04 Mar 2026 |
Form 4: Beetham Thomas W., Chief Operating Officer
Granted 176,550 Stock Option (Right to Buy) · Granted 35,300 Restricted Stock Units · Received 9,409 shares by exercise or conversion · 1 more |
| 04 Mar 2026 |
Form 4: Mahoney Stephen F., President and CEO
Granted 559,600 Stock Option (Right to Buy) · Granted 111,900 Restricted Stock Units · Received 18,357 shares by exercise or conversion · 1 more |
| 04 Mar 2026 |
Form 4: Tripuraneni Radhika, Chief Medical Officer
Granted 95,800 Stock Option (Right to Buy) · Granted 19,150 Restricted Stock Units |
| 02 Jan 2026 |
Form 4: Tousignant Jennifer, Chief Legal Officer
Sold 2,272 shares ($70.8K) |
| 27 Oct 2025 |
Form 4: Fairmount Funds Management Llc, Director and 2 others
Bought 454,545 shares ($10M) |
| 02 Jul 2025 |
Form 4: Cain Christopher W., Director
Granted 21,000 Stock Option (Right to Buy) |
| 02 Jul 2025 |
Form 4: Kiselak Tomas, Director
Granted 21,000 Stock Option (Right to Buy) |
| 02 Jul 2025 |
Form 4: Morris Arlene, Director
Granted 21,000 Stock Option (Right to Buy) |
| 02 Jul 2025 |
Form 4: Ajer Jeffrey Robert, Director
Granted 21,000 Stock Option (Right to Buy) |
Loading...